EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Early treatment in migraine – A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society

Patricia Pozo-Rosich iD, Edoardo Caronna iD, Simona Sacco iD, Mario F P Peres iD, Sait Ashina iD, Aynur Özge iD, Fayyaz Ahmed, Maria Karina Velez-Jimenez, Bronwyn Jenkins, Shuu-Jiun Wang iD, Todd J Schwedt iD, Fumihiko Sakai und 4 weitere

Cephalalgia · 2025-10 · 45 (10)

DOI: 10.1177/03331024251387721 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cephalalgia, online erschienen am 24.10.2025. Verfasst von Patricia Pozo-Rosich und 15 weiteren Autor:innen. Beteiligte Einrichtung: Headache Clinic, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain. Hauptthemen laut MEDLINE: Migraine Disorders. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Migraine is one of the most disabling diseases worldwide, especially when it transforms into chronic migraine, which is often associated with medication overuse and can become resistant or even refractory to treatments. Molecular, neuroimaging and neurophysiological changes have been described in chronic migraine, some of which might not be fully reversible with preventive treatment. For these reasons, we should aim to prevent this transition, and initiate preventive treatment before disease becomes refractory and burden increases. Preventive migraine treatments are often delayed because of access to care, stigma leading to undertreatment and patients’ reluctance as a result of fear of side effects and, in some cases, fear of being labeled as chronically ill. With the availability of effective and well-tolerated preventive treatments, we must shift our mindset and take advantage of new opportunities to initiate preventive treatment earlier. In this International Headache Society position statement, we propose a migraine preventive strategy under the idea of shifting from reactive treatment once disability is established (prevention of attacks), to proactive, individualized prevention initiated early with safe, effective and tolerable therapies (prevention of disease progression). This approach is based on 1) promoting the early initiation of effective and tolerable preventive therapies, starting from two to four monthly migraine days in line with the majority of current guidelines and recommendations and 2) fostering longitudinal studies to gather more evidence on the potential benefit of early prevention, with the final goal of improving patient outcomes, promoting excellent migraine care, enhancing individual and social well-being, and, ultimately, preventing migraine progression and preserving brain health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersHumansDisease ProgressionSocieties, Medical

Stichwörter der Autor:innen

anti-CGRP therapiesmigraine preventive treatmentpreventive treatmenttreatment outcomes

Autor:innen und Institutionen

  • Headache Clinic, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Headache and Neurological Pain Research Group, Vall d'Hebron Research Institute, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Institute of Psychiatry, HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Department of Neurology, Hospital Albert Einstein, São Paulo, Brazil.
  • Department of Neurology Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.

ORCID-Profile: Patricia Pozo-Rosich, Edoardo Caronna, Simona Sacco, Mario F P Peres, Sait Ashina, Aynur Özge, Shuu-Jiun Wang, Todd J Schwedt, Rami Burstein, Gisela M Terwindt, Cristina Tassorelli

Zitieren

APA

Pozo-Rosich, P., Caronna, E., Sacco, S., Peres, M. F. P., Ashina, S., Özge, A., Ahmed, F., Velez-Jimenez, M. K., Jenkins, B., Wang, S. J., Schwedt, T. J., Sakai, F., Levin, M., Burstein, R., Terwindt, G. M., & Tassorelli, C. (2025). Early treatment in migraine – A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society. Cephalalgia, 45(10). https://doi.org/10.1177/03331024251387721

Vancouver

Pozo-Rosich P, Caronna E, Sacco S, Peres MFP, Ashina S, Özge A, et al. Early treatment in migraine – A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society. Cephalalgia. 2025;45(10). doi:10.1177/03331024251387721

BibTeX
@article{PozoRosich2025,
  author = {Pozo-Rosich, Patricia and Caronna, Edoardo and Sacco, Simona and Peres, Mario F P and Ashina, Sait and Özge, Aynur and Ahmed, Fayyaz and Velez-Jimenez, Maria Karina and Jenkins, Bronwyn and Wang, Shuu-Jiun and Schwedt, Todd J and Sakai, Fumihiko and Levin, Morris and Burstein, Rami and Terwindt, Gisela M and Tassorelli, Cristina},
  title = {Early treatment in migraine – A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society},
  journal = {Cephalalgia},
  year = {2025},
  volume = {45},
  number = {10},
  doi = {10.1177/03331024251387721}
}
Kostenlos starten →